173 related articles for article (PubMed ID: 21970873)
1. Expression and prognostic value of transcription factor PROX1 in colorectal cancer.
Skog M; Bono P; Lundin M; Lundin J; Louhimo J; Linder N; Petrova TV; Andersson LC; Joensuu H; Alitalo K; Haglund CH
Br J Cancer; 2011 Oct; 105(9):1346-51. PubMed ID: 21970873
[TBL] [Abstract][Full Text] [Related]
2. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer.
Abdelrahman AE; El-Azony A; Elsebai E; Ibrahim HM
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):126-135. PubMed ID: 34657081
[TBL] [Abstract][Full Text] [Related]
4. Transcription Factor PROX1 Suppresses Notch Pathway Activation via the Nucleosome Remodeling and Deacetylase Complex in Colorectal Cancer Stem-like Cells.
Högström J; Heino S; Kallio P; Lähde M; Leppänen VM; Balboa D; Wiener Z; Alitalo K
Cancer Res; 2018 Oct; 78(20):5820-5832. PubMed ID: 30154153
[TBL] [Abstract][Full Text] [Related]
5. PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.
Jernman J; Kallio P; Hagström J; Välimäki MJ; Haapasalo H; Alitalo K; Arola J; Haglund C
Virchows Arch; 2015 Sep; 467(3):279-84. PubMed ID: 26063416
[TBL] [Abstract][Full Text] [Related]
6. PROX1 is a predictor of survival for gliomas WHO grade II.
Elsir T; Qu M; Berntsson SG; Orrego A; Olofsson T; Lindström MS; Nistér M; von Deimling A; Hartmann C; Ribom D; Smits A
Br J Cancer; 2011 May; 104(11):1747-54. PubMed ID: 21559010
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype.
Petrova TV; Nykänen A; Norrmén C; Ivanov KI; Andersson LC; Haglund C; Puolakkainen P; Wempe F; von Melchner H; Gradwohl G; Vanharanta S; Aaltonen LA; Saharinen J; Gentile M; Clarke A; Taipale J; Oliver G; Alitalo K
Cancer Cell; 2008 May; 13(5):407-19. PubMed ID: 18455124
[TBL] [Abstract][Full Text] [Related]
8. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
[TBL] [Abstract][Full Text] [Related]
9. Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression.
Yu EJ; Kim SH; Kim HJ; Heo K; Ou CY; Stallcup MR; Kim JH
Oncogene; 2016 Jun; 35(26):3410-8. PubMed ID: 26477307
[TBL] [Abstract][Full Text] [Related]
10. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
[TBL] [Abstract][Full Text] [Related]
11. High PROX1 expression in gastric cancer predicts better survival.
Laitinen A; Böckelman C; Hagström J; Kokkola A; Kallio P; Haglund C
PLoS One; 2017; 12(8):e0183868. PubMed ID: 28854215
[TBL] [Abstract][Full Text] [Related]
12. Prospero homeobox 1 mediates the progression of gastric cancer by inducing tumor cell proliferation and lymphangiogenesis.
Park KJ; Cho SB; Park YL; Kim N; Park SY; Myung DS; Lee WS; Kweon SS; Joo YE
Gastric Cancer; 2017 Jan; 20(1):104-115. PubMed ID: 26759228
[TBL] [Abstract][Full Text] [Related]
13. PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas.
Ramani P; Norton A; Somerville MS; May MT
J Neurooncol; 2012 Jul; 108(3):375-83. PubMed ID: 22382784
[TBL] [Abstract][Full Text] [Related]
14. High Expression of Prospero-Related Homeobox-1 (PROX1) Is Associated With Poor Prognosis in Patients With Salivary Adenoid Cystic Carcinoma.
Gao T; Ma C; Li Y; Ju J; Kang X; Cai Y; Sun M
J Oral Maxillofac Surg; 2018 Jul; 76(7):1440-1446. PubMed ID: 29406257
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205 - PROX1 mechanism.
Nguyen-Vu T; Wang J; Mesmar F; Mukhopadhyay S; Saxena A; McCollum CW; Gustafsson JÅ; Bondesson M; Williams C
Oncotarget; 2016 Jul; 7(27):42159-42171. PubMed ID: 27283988
[TBL] [Abstract][Full Text] [Related]
16. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
[TBL] [Abstract][Full Text] [Related]
17. Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype.
Goudarzi KM; Espinoza JA; Guo M; Bartek J; Nistér M; Lindström MS; Hägerstrand D
Cancer Res; 2018 Oct; 78(20):5901-5916. PubMed ID: 30135192
[TBL] [Abstract][Full Text] [Related]
18. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
[TBL] [Abstract][Full Text] [Related]
20. Prox1 promotes expansion of the colorectal cancer stem cell population to fuel tumor growth and ischemia resistance.
Wiener Z; Högström J; Hyvönen V; Band AM; Kallio P; Holopainen T; Dufva O; Haglund C; Kruuna O; Oliver G; Ben-Neriah Y; Alitalo K
Cell Rep; 2014 Sep; 8(6):1943-1956. PubMed ID: 25242330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
